You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Eurand, Inc. v. Anchen Pharmaceuticals, Inc.

Citation: 427 F. App'x 901Docket: Nos. 2011-1408, 2011-1410, 2011-1411, 2011-1412

Court: Court of Appeals for the Federal Circuit; August 31, 2011; Federal Appellate Court

Narrative Opinion Summary

The appellants' motion to withdraw their appeals is granted, resulting in the dismissal of the appeals. Additionally, the motion to revise the official caption is approved, with the updated caption now in effect. Each party will bear its own costs, and any other pending motions are denied as moot.

Legal Issues Addressed

Allocation of Costs

Application: The court determined that each party is responsible for its own costs in this case.

Reasoning: Each party will bear its own costs.

Denial of Moot Motions

Application: The court denied all other pending motions as moot.

Reasoning: Any other pending motions are denied as moot.

Motion to Withdraw Appeals

Application: The court approved the appellants' request to withdraw their appeals, leading to the dismissal of those appeals.

Reasoning: The appellants' motion to withdraw their appeals is granted, resulting in the dismissal of the appeals.

Revision of Official Caption

Application: The court approved the motion to change the official caption, and the updated caption is now in effect.

Reasoning: Additionally, the motion to revise the official caption is approved, with the updated caption now in effect.